Skip to main content
logo
Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
165.10
+11.20 (7.28%)
Oct 14, 2026, 4:08 PM HKT

HKG:2637 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
12,99510,704---
Market Cap Growth
-----
Enterprise Value
11,46410,420---
Last Close Price
165.10136.00---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
71.6254.34---
PS Ratio
18.9516.52---
PB Ratio
6.746.04---
P/TBV Ratio
6.866.04---
P/FCF Ratio
-83.58---
P/OCF Ratio
-60.16---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
16.7216.08---
EV/EBITDA Ratio
53.2347.32---
EV/EBIT Ratio
55.9648.70---
EV/FCF Ratio
-81.36---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.060.070.110.120.32
Debt / EBITDA Ratio
0.530.550.410.401.11
Debt / FCF Ratio
-0.96-0.571.12
Net Debt / Equity Ratio
-0.79-0.77-0.40-0.55-0.76
Net Debt / EBITDA Ratio
-7.19-6.17-1.59-1.83-2.67
Net Debt / FCF Ratio
--10.6014.80-2.54-2.67
Asset Turnover
-0.450.710.65-
Inventory Turnover
-2.122.641.99-
Quick Ratio
6.546.061.712.643.57
Current Ratio
6.856.311.902.853.89
Return on Equity (ROE)
-16.58%28.75%33.90%-
Return on Assets (ROA)
-9.23%12.62%15.30%-
Return on Invested Capital (ROIC)
48.64%49.21%48.05%85.60%110.84%
Return on Capital Employed (ROCE)
10.20%11.90%23.20%27.10%24.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
1.34%1.84%---
FCF Yield
-1.20%---
Buyback Yield / Dilution
-11.98%-3.42%--4.57%-